Breaking News
October 16, 2018 - Global study finds youngest in class more likely to be diagnosed with ADHD
October 16, 2018 - Researchers sequence two selfish genes in the fungus Neurospora intermedia
October 16, 2018 - Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis
October 16, 2018 - Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration
October 16, 2018 - Researchers create open access database on healthy immunity
October 16, 2018 - Rice University chemist wins big award to study small surfaces
October 16, 2018 - Study finds 43% drop in stroke rate
October 16, 2018 - Researchers identify basic relationships of cell cycle and cellular senescence in the placenta
October 16, 2018 - Obesity Doubles Odds for Colon Cancer in Younger Women
October 16, 2018 - Adults with ADHD not constrained in creativity
October 16, 2018 - Raising visibility for people and students with chronic illness and disability
October 16, 2018 - Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis
October 16, 2018 - Only 59% of young adults undergoing surgery are fluid responsive
October 16, 2018 - Research points to potential new treatment for hearing loss
October 16, 2018 - MDI Biological Laboratory receives $1.2 million SEPA grant to promote data literacy
October 16, 2018 - Vast majority of dementia cases may arise from spontaneous genetic errors
October 16, 2018 - New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases
October 16, 2018 - Study identifies molecular switch that controls fate of milk-producing breast cells
October 16, 2018 - Research shows diet has little influence on precursor to gout
October 16, 2018 - “Without Dr. Shumway doing his miracle work, three generations would not be here”: A Stanford heart transplant patient’s story
October 16, 2018 - Non-invasive brain stimulation sheds light on neurobiology underlying implicit bias
October 16, 2018 - Researchers demonstrate integrated technique to control production of cell therapeutics
October 16, 2018 - Breast tomosynthesis detects 34% more tumors than traditional mammography
October 16, 2018 - Rhode Island Hospital, Brown receive $800,000 grant to keep up fight against opioid epidemic
October 16, 2018 - UVA partners with health systems in AVIA network’s Medicaid Transformation Project
October 16, 2018 - Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
October 16, 2018 - Study reveals early warning signs of heart problems in patients with newly diagnosed lupus
October 16, 2018 - Connecting the dots of Alzheimer’s disease
October 16, 2018 - New publication offers evidence-based content for global breast imaging medical community
October 16, 2018 - ‘EinsteinVision’ that improves hand-eye coordination of surgeons introduced at Harefield Hospital
October 16, 2018 - WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine
October 16, 2018 - Ketamine can be considered as alternative to opioids for short-term pain control in ED
October 16, 2018 - Endurance exercise training beneficially alters gut microbiota composition
October 15, 2018 - FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
October 15, 2018 - Birthing Options for Full-Term Pregnancy
October 15, 2018 - Stressed, toxic, zombie cells seen for first time in Alzheimer’s
October 15, 2018 - Concussion researchers study head motion in high school football hits | News Center
October 15, 2018 - Neuropsychiatric symptoms related to earliest stages of Alzheimer’s brain pathology
October 15, 2018 - Neck collar device may help protect the brain of female high school soccer players
October 15, 2018 - Research reveals how the inner ear processes speech
October 15, 2018 - Many parents still skeptical about safety and effectiveness of flu shot, survey finds
October 15, 2018 - Payer Policies May Discourage Non-Pharma Tx for Low Back Pain
October 15, 2018 - Exercise may delay cognitive decline in people with rare Alzheimer’s disease
October 15, 2018 - Researchers modify CRISPR to reorganize genome | News Center
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Study highlights need for increased support for alcohol-related liver disease patients
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Schiller Easy Pulse Saves Lives
October 15, 2018 - The latest ECG device from Schiller
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
October 15, 2018 - Engineering teratoma-derived fibroblasts to enhance osteogenesis
October 15, 2018 - Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism
October 15, 2018 - JCU study firms up association between diet and depression
October 15, 2018 - Researchers to study the use of CRISPR on human liver on-a-chip platform
October 15, 2018 - Sub-concussive impacts not associated with decline in neurocognitive function
October 15, 2018 - Researchers find potential treatment to halt premature labor and birth
October 15, 2018 - As U.S. suicides rates rise, Hispanics show relative immunity
October 15, 2018 - FDA Issues a Complete Response Letter to Acacia Pharma for Barhemsys
October 15, 2018 - Photoactive bacteria bait may help in fight against MRSA infections
October 15, 2018 - Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children
October 15, 2018 - First-of-its-kind study to test a personalized vaccine in cancer patient
October 15, 2018 - Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia
October 15, 2018 - Half of parents say young children are afraid of doctor’s visits
UM SOM learn about unearths intriguing courting between sleep, cognition and kynurenine compound

UM SOM learn about unearths intriguing courting between sleep, cognition and kynurenine compound

image_pdfDownload PDFimage_print

Greater than three.2 million American citizens be afflicted by schizophrenia; about 100,000 persons are newly identified once a year. The illness contains quite a lot of signs together with visible and auditory hallucinations, cognitive issues and motivational problems. A key factor with the illness, and one who will get much less consideration than different signs, is cognitive issues. Many with the illness have hassle with finding out and reminiscence. For lots of, that is the primary signal of the illness.

A brand new learn about by means of researchers on the College of Maryland Faculty of Medication (UM SOM) has discovered intriguing hyperlinks between sleep, cognition and a compound known as kynurenine. Those hyperlinks may just remove darkness from the mechanism that reasons cognitive issues amongst the ones with the illness, and may just level how to new therapies to scale back one of the vital illness’s signs.

The findings had been printed these days within the magazine Sleep. The learn about is the primary to remove darkness from intimately the hyperlinks between kynurenine, its metabolite kynurenic acid, sleep and cognition.

“No person has seemed carefully on the courting between sleep and the kynurenine pathway prior to,” mentioned Ana Pocivavsek, a researcher on the UM SOM Maryland Psychiatric Analysis Heart (MPRC) and an assistant professor within the Division of Psychiatry. “This analysis establishes a transparent hyperlink between elevations in kynurenine and sleep issues.”

Lately, scientists have recognized kynurenic acid as a possible key participant in schizophrenia. Kynurenic acid is a neuroactive metabolite of kynurenine this is shaped within the mind. Other people with schizophrenia have upper than standard ranges of kynurenic acid of their brains. Scientists have theorized that those increased ranges could be hooked up with a spread of signs noticed within the illness, together with issues of finding out and reminiscence.

The mechanisms underlying the cognitive impairments in sufferers, on the other hand, have remained unclear. Dr. Pocivavsek and her colleagues suspected that an interaction between increased kynurenic acid and sleep may just play a task. There may be a large number of proof in each people and animals that sleep disorder ends up in issues of finding out and reminiscence. As well as, researchers and clinicians have lengthy famous that folks with schizophrenia steadily have issues of sleep as smartly.

For those experiments, she and her colleagues studied rats. They made comparisons within the habits of rats with greater kynurenic acid of their brains to animals with standard ranges of the compound. They hooked up the animals’ brains to a tool that measured the volume and high quality of sleep, and located that the animals with upper ranges of kynurenic acid had considerably much less speedy eye motion, or REM, sleep. That is the sleep section through which goals happen, and it’s regarded as crucial for the consolidation of earlier finding out.

The researchers discovered that the gang with top kynurenic acid additionally had issues of finding out. To check this, they position rats in a field and shine mild into the field. On one aspect of the field there may be a gap right into a darker house. Rats are nocturnal animals, and like the darkish, so the animals in most cases run to the darkish house. As soon as on this house, they obtain a small electrical surprise. When the experiment is repeated tomorrow, standard animals don’t run to the darker house, remembering the surprise from the day prior to. By way of comparability, animals with greater ranges of top kynurenic acid, and thus impaired sleep, don’t take into account the surprise from the day prior to, and run into the darkish house. In different phrases they didn’t be told from the day gone by’s enjoy.

“What we are beginning to take into consideration is that kynurenic acid disrupts sleep, which then disrupts cognition,” she mentioned. Then again, there are different probabilities, she says: it can be that disruptions in sleep reason greater kynurenic acid, which then ends up in cognitive issues. “It isn’t transparent which occurs first,” she says. “That may be a in point of fact attention-grabbing query, and one who we’re investigating.”

Dr. Pocivavsek and different researchers theorize that lowering kynurenic acid may just scale back issues of sleep and cognition in sufferers with schizophrenia. “We unquestionably imagine that prime ranges of kynurenic acid are a the most important side of schizophrenia,” she says.

The analysis supplies extra reason why to increase medications that scale back kynurenic acid ranges within the mind. One key chance is to inhibit an enzyme known as kynurenine aminotransferase II, or KAT II, which converts kynurenine to kynurenic acid. The use of compounds that inhibit this enzyme, researchers had been in a position to scale back the volume of kynurenic acid within the mind. Over time, quite a lot of pharmaceutical firms have labored to increase inhibitors of KAT II that may achieve the mind, and can be secure and efficient in people. Dr. Pocivavsek’s analysis supplies proof that this way has scientific possible.

“This learn about provides to the proof that prime ranges of kynurenic acid give a contribution to cognitive disorder,” she says. “If we will be able to get a hold of techniques to scale back the ones ranges, we could possibly scale back those signs for sufferers.”


Tagged with:

About author

Related Articles